2D-BioPAD and MUNASET at Graphene Week 2025: Showcasing Graphene-Based Biomedical Innovatio
2D-BioPAD and MUNASET at Graphene Week 2025: Showcasing Graphene-Based Biomedical Innovation
News articles
MUNASET publishes a perspective piece on graphene-based biosensors and their use in the prediction of depression
Emergence of graphene-based biosensors for improved treatment response prediction in major depressive disorder: a perspective.
Enabling EU-funded project collaboration for brain health R&I
Enabling EU-funded project collaboration for brain health R&I
2D Materials Innovation for Biomedical Applications
RIA PULSE: 4 HORIZON EUROPE PROJECTS IN ACTION
Partnerships strengthened during Graphene Week 2024
Joint Biomed Workshop during Graphene Week 2024 strengthens collaboration between 2D-BioPAD and MUNASET projects
MUNASET: Month 6 meeting took place in Zweibruecken 29 February 2024
Partners from the MUNASET project met to report their progress and set the objectives for upcoming work.
MUNASET: A new Horizon Europe project kicked off
Proteases recently emerged as a promising new class of biomarkers with a broad diagnostic, prognostic and therapeutic potential for different human diseases including neurological and psychiatric diseases, several types of cancer and immune system disorders. However, there is a lack of tools for real-time activity analysis of disease-related protease biomarkers.